Analysis of transport and targeting of syndecan-1: effect of cytoplasmic tail deletions

HM Miettinen, SN Edwards and M Jalkanen

Centre for Biotechnology, Turku, Finland.

Madin-Darby canine kidney (MDCK) cells and Chinese hamster ovary (CHO) cells were transfected with wild-type and cytoplasmic deletion mutants of mouse syndecan-1 to study the requirements for transport and polarized expression of this proteoglycan. Expression in MDCK cells revealed that wild-type syndecan-1 is directed to the basolateral surface via a brefeldin A-insensitive route. A deletion of the last 12 amino acids of the syndecan-1 cytoplasmic tail (CT22) was sufficient to result in the appearance of mutant proteoglycans at both the basolateral and apical cell surfaces. Treatment with brefeldin A was able to prevent apical transport of the mutants. We thus propose that the C-terminal part of the cytoplasmic tail is required for steady- state basolateral distribution of syndecan-1. In CHO cells a deletion of the last 25 or 33 amino acids of the 34-residue cytoplasmic domain (CT9 and CT1, respectively) resulted in partial retention of the mutants in the endoplasmic reticulum (ER). A deletion mutant lacking the last 12 amino acids (CT22) was not retained. Interestingly, the unglycosylated core proteins of the CT9 and CT1 mutants showed a significantly lower apparent molecular weight when analyzed by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis than wild-type syndecan-1. However, when CHO transfectants expressing the CT1 mutant were incubated with brefeldin A, causing fusion of the ER and Golgi, CT1 ran with an almost equally high apparent molecular weight as the wild-type molecule. This would suggest that syndecan-1 undergoes extensive posttranslational modifications or forms an SDS-resistant dimer/complex after transit from the ER.

Volume 5, Issue 12, pp. 1325-1339, 12/01/1994
Copyright © 1994 by The American Society for Cell Biology

This article has been cited by other articles:

				G. Levallet, J. Levallet, and P.-J. Bonnamy FSH-induced phosphoprotein phosphatase 2A-mediated deactivation of particulate phosphodiesterase-4 activities is abolished after alteration in proteoglycan synthesis in immature rat Sertoli cells J. Endocrinol., April 1, 2008; 197(1): 45 - 54. [Abstract] [Full Text] [PDF]

				K. J. Yu, A. Bashirova, M. M. Madeleine, J. Cheng, L. G. Johnson, S. M. Schwartz, M. Carrington, and A. Hildesheim Evaluation of the Association with Cervical Cancer of Polymorphisms in Syndecan-1, a Heparan Sulfate Proteoglycan Involved with Viral Cell Entry Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2504 - 2508. [Abstract] [Full Text] [PDF]

				R. Chakravarti, V. Sapountzi, and J. C. Adams Functional Role of Syndecan-1 Cytoplasmic V Region in Lamellipodial Spreading, Actin Bundling, and Cell Migration Mol. Biol. Cell, August 1, 2005; 16(8): 3678 - 3691. [Abstract] [Full Text] [PDF]

				W. B. Stallcup and K. Dahlin-Huppe Chondroitin sulfate and cytoplasmic domain-dependent membrane targeting of the NG2 proteoglycan promotes retraction fiber formation and cell polarization J. Cell Sci., March 8, 2002; 114(12): 2315 - 2325. [Abstract] [Full Text] [PDF]

				J. C. Adams, N. Kureishy, and A. L. Taylor A Role for Syndecan-1 in Coupling Fascin Spike Formation by Thrombospondin-1 J. Cell Biol., March 19, 2001; 152(6): 1169 - 1182. [Abstract] [Full Text] [PDF]

				C. Klass, J. Couchman, and A Woods Control of extracellular matrix assembly by syndecan-2 proteoglycan J. Cell Sci., January 2, 2000; 113(3): 493 - 506. [Abstract] [PDF]

				K Prydz and K. Dalen Synthesis and sorting of proteoglycans J. Cell Sci., January 1, 2000; 113(2): 193 - 205. [Abstract] [PDF]

				P. ZIMMERMANN and G. DAVID The syndecans, tuners of transmembrane signaling FASEB J, May 1, 1999; 13(9001): 91 - 100. [Abstract] [Full Text] [PDF]

				S. Kolset, T. Vuong, and K Prydz Apical secretion of chondroitin sulphate in polarized Madin-Darby canine kidney (MDCK) cells J. Cell Sci., January 6, 1999; 112(11): 1797 - 1801. [Abstract] [PDF]

				F. Petersen, L. Bock, H.-D. Flad, and E. Brandt A Chondroitin Sulfate Proteoglycan on Human Neutrophils Specifically Binds Platelet Factor 4 and Is Involved in Cell Activation J. Immunol., October 15, 1998; 161(8): 4347 - 4355. [Abstract] [Full Text] [PDF]

				A. R. Cohen, D. F. Wood, S. M. Marfatia, Z. Walther, A. H. Chishti, and J. M. Anderson Human CASK/LIN-2 Binds Syndecan-2 and Protein 4.1 and Localizes to the Basolateral Membrane of Epithelial Cells J. Cell Biol., July 13, 1998; 142(1): 129 - 138. [Abstract] [Full Text] [PDF]

				E.-S. Oh, A. Woods, and J. R. Couchman Multimerization of the Cytoplasmic Domain of Syndecan-4 Is Required for Its Ability to Activate Protein Kinase C J. Biol. Chem., May 2, 1997; 272(18): 11805 - 11811. [Abstract] [Full Text] [PDF]

				A Simonsen, E Stang, B Bremnes, M Roe, K Prydz, and O Bakke Sorting of MHC class II molecules and the associated invariant chain (Ii) in polarized MDCK cells J. Cell Sci., January 3, 1997; 110(5): 597 - 609. [Abstract] [PDF]

				T. Vihinen, A. Määttä, P. Jaakkola, P. Auvinen, and M. Jalkanen Functional Characterization of Mouse Syndecan-1 Promoter J. Biol. Chem., May 24, 1996; 271(21): 12532 - 12541. [Abstract] [Full Text] [PDF]

				S Leppa, K Vleminckx, F Van Roy, and M Jalkanen Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent J. Cell Sci., January 6, 1996; 109(6): 1393 - 1403. [Abstract] [PDF]